Interleukin-12 Requires Initial CD80-mediated T-Cell Activation to Support Immune Responses Toward Human Breast and Ovarian Carcinoma

Cancer Gene Therapy - United Kingdom
doi 10.1038/sj.cgt.7700050

Related search